BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 19318808)

  • 1. Primary cutaneous peripheral T-cell lymphoma with aberrant coexpression of CD20: case report and review of the literature.
    Balmer NN; Hughey L; Busam KJ; Reddy V; Andea AA
    Am J Dermatopathol; 2009 Apr; 31(2):187-92. PubMed ID: 19318808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD20-Positive nodal natural killer/T-cell lymphoma with cutaneous involvement.
    Tsai YC; Chen CK; Wu YH
    J Cutan Pathol; 2015 Sep; 42(9):639-44. PubMed ID: 25924981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary Central Nervous System T-Cell Lymphoma With Aberrant Expression of CD20 and CD79a: A Diagnostic Pitfall.
    Gupta N; Nasim M; Spitzer SG; Zhang X
    Int J Surg Pathol; 2017 Oct; 25(7):599-603. PubMed ID: 28612664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary Cutaneous T-cell Lymphoma With Aberrant CD-20 Expression.
    Karimkhani C; McLaughlin C; Smith C
    J Drugs Dermatol; 2015 May; 14(5):515-6. PubMed ID: 25942672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary cutaneous CD20-positive T-cell lymphoma.
    Martin B; Stefanato C; Whittaker S; Robson A
    J Cutan Pathol; 2011 Aug; 38(8):663-9. PubMed ID: 21623866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary cutaneous CD56 positive lymphoma: a diagnostic conundrum in an unusual case of lymphoma.
    Schieke SM; Sharaf MA; Lerner A; Rünger TM; Mahalingam M
    J Cutan Pathol; 2012 May; 39(5):540-4. PubMed ID: 22519525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An unusual case report of indolent T-cell lymphoproliferative disorder with aberrant CD20 expression involving the gastrointestinal tract and bone marrow.
    Wang X; Ng CS; Chen C; Yu G; Yin W
    Diagn Pathol; 2018 Oct; 13(1):82. PubMed ID: 30342536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD3 and CD20 Coexpression in a Case of Canine Cutaneous Epitheliotropic T-Cell Lymphoma (Mycosis Fungoides).
    Brachelente C; Affolter VK; Fondati A; Porcellato I; Sforna M; Lepri E; Mechelli L; Bongiovanni L
    Vet Pathol; 2016 May; 53(3):563-6. PubMed ID: 26354309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral T-cell lymphoma with aberrant expression of CD79a and CD20: a diagnostic pitfall.
    Yao X; Teruya-Feldstein J; Raffeld M; Sorbara L; Jaffe ES
    Mod Pathol; 2001 Feb; 14(2):105-10. PubMed ID: 11235901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous mantle cell lymphoma histomorphologically mimicking subcutaneous panniculitis-like T-cell lymphoma: Case report.
    Laggis C; Miles R; Stephens DM; Duffy K; Bowen A; Wada D
    J Cutan Pathol; 2019 Jul; 46(7):538-541. PubMed ID: 30957249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Primary bone marrow CD8 cytotoxic T-cell lymphoma coexpressed CD20: a case report and literatures review].
    Jin X; Zhi YQ; Yu Y; Zhang YZ; Zhang L
    Zhonghua Xue Ye Xue Za Zhi; 2013 Mar; 34(3):229-32. PubMed ID: 23683422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous T-cell lymphoma with massive co-infiltration of polyclonal B cells.
    Yagi H; Ogai M; Izumi T; Ebihara T; Sugiura M; Tokura Y; Takigawa M
    Br J Dermatol; 1994 Feb; 130(2):226-30. PubMed ID: 7510123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of hepatosplenic gammadelta T cell lymphoma].
    Wang FX; Zhang XJ; Dong ZR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):505-8. PubMed ID: 15972153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous B-cell lymphoma with loss of CD20 immunoreactivity after rituximab therapy.
    Clarke LE; Bayerl MG; Ehmann WC; Helm KF
    J Cutan Pathol; 2003 Aug; 30(7):459-62. PubMed ID: 12859745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD20+ T-cell lymphoma. Neoplastic transformation of a normal T-cell subset.
    Quintanilla-Martinez L; Preffer F; Rubin D; Ferry JA; Harris NL
    Am J Clin Pathol; 1994 Oct; 102(4):483-9. PubMed ID: 7524302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD20-positive T-cell lymphoma with indolent clinical behaviour.
    Xiao WB; Wang ZM; Wang LJ
    J Int Med Res; 2010; 38(3):1170-4. PubMed ID: 20819457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary cutaneous follicle center lymphoma with aberrant CD8 expression.
    Lee J; Cohen JA; Wrone DA; Gru AA
    J Cutan Pathol; 2022 Apr; 49(4):403-407. PubMed ID: 34797569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multispectral Imaging Approach to the Diagnosis of a CD20+ Cutaneous T-cell Lymphoproliferative Disorder: A Case Report.
    Salva KA; Bennett D; Longley J; Guitart J; Wood GS
    Am J Dermatopathol; 2015 Oct; 37(10):e116-21. PubMed ID: 26381030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD20-positive primary nasal peripheral T-cell lymphoma: An analysis of one case and review of the literature.
    Li YL; Wang HP; Zhang C; Zhai ZM
    Cytometry B Clin Cytom; 2020 Jul; 98(4):348-354. PubMed ID: 31682318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD20 positive mycosis fungoides: a case report.
    Sen F; Kang S; Cangiarella J; Kamino H; Hymes K
    J Cutan Pathol; 2008 Apr; 35(4):398-403. PubMed ID: 18261116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.